Icosapent ethyl for treatment of elevated triglyceride levels (Q38164650)

30 August 2017

title

Icosapent ethyl for treatment of elevated triglyceride levels (English)

1 reference

30 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Mark A Munger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

5 November 2013

1 reference

Annals of Pharmacotherapy

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

8 June 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

8 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

1517-1523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Hypertriglyceridemia as a Cardiovascular Risk Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Chylomicronemia and the chylomicronemia syndrome: a practical approach to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Hypertriglyceridemia: its etiology, effects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Safety considerations with omega-3 fatty acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Expert opinion: omega-3 fatty acids and bleeding-cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Clinical practice. Hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

The effect of alcohol on postprandial and fasting triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Evidence that triglycerides are an independent coronary heart disease risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Hypertriglyceridemia and its pharmacologic treatment among US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1060028013504079

21 January 2018

Identifiers

DOI

10.1177/1060028013504079

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24259598 AND SRC:MED&resulttype=core&format=json

8 June 2020

1 reference